Daratumumab rapidly reduces high-titre factor VIII inhibitors in haemophilia A patients during life-threatening haemorrhages

Haemophilia. 2021 Jan;27(1):e155-e159. doi: 10.1111/hae.14118. Epub 2020 Aug 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Factor VIII*
  • Hemophilia A* / drug therapy
  • Hemorrhage / etiology
  • Humans

Substances

  • Antibodies, Monoclonal
  • daratumumab
  • Factor VIII